Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756673 · ClinicalTrials.gov registry record · Phase 4
A Study of Virtually Supervised Mouthwash and Interdental Brushes
A Phase 4 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 4
- Development phase
- 292
- Enrollment target
NCT05756673: Completed Phase 4 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
NCT05756673 is a Phase 4 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 292 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05756673, a Phase 4 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 292 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the relative effectiveness of oral (mouth) care regimens for the avoidance and treatment of plaque and gingivitis.
Primary Outcome
Interproximal mean TPI after 24 weeks of product use will be reported. Plaque area will be scored by the Turesky Modification of the Quigley-Hein Plaque Index, on 6 surfaces (distobuccal, midbuccal and mesiobuccal, distolingual, midlingual and mesiolingual) of all scorable teeth, following disclosing: 0 (no plaque); 1 (separate flecks or discontinuous band of plaque around the gingival (cervical) margin); 2 (thin, up to 1 millimeter \[mm\]), continuous band of plaque at the gingival margin); 3 (
Interventions
- DRUG Colgate Cavity Protection Toothpaste
- DRUG LISTERINE ZERO Alcohol Mouthwash COOL MINT
- DRUG LISTERINE COOL MINT Antiseptic Mouthwash
- DEVICE TePe Original Interdental Brush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2023-02-09 |
| Est. Completion | 2023-10-03 |
| Phase | Phase 4 |
What the finished NCT05756673 record still lists
NCT05756673 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 4 interventions - of which Colgate Cavity Protection Toothpaste is the first listed.
NCT05756673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05756673 about?
NCT05756673 is a clinical study titled "A Study of Virtually Supervised Mouthwash and Interdental Brushes". The purpose of this study is to assess the relative effectiveness of oral (mouth) care regimens for the avoidance and treatment of plaque and gingivitis.
What is the current status of trial NCT05756673?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 292 participants. The study started on 2023-02-09. Estimated completion is 2023-10-03.
What interventions are being tested in trial NCT05756673?
The interventions under investigation include: Colgate Cavity Protection Toothpaste (DRUG), LISTERINE ZERO Alcohol Mouthwash COOL MINT (DRUG), LISTERINE COOL MINT Antiseptic Mouthwash (DRUG), TePe Original Interdental Brush (DEVICE).
Who is sponsoring clinical trial NCT05756673?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05756673's enrollment target sits among peer trials
292 296th of 2000 higher than 1,704 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- NCT05406622 · 292 participants · NA
MOTIV BTK Randomized Controlled Trial
- NCT05757102 · 292 participants · Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- NCT06569667 · 292 participants · NA
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI